Bioengineering a bacterial pathogen to assemble its own particulate vaccine capable of inducing cellular immunity

Sci Rep. 2017 Feb 2:7:41607. doi: 10.1038/srep41607.

Abstract

Many bacterial pathogens naturally form cellular inclusions. Here the immunogenicity of polyhydroxyalkanoate (PHA) inclusions and their use as particulate vaccines delivering a range of host derived antigens was assessed. Our study showed that PHA inclusions of pathogenic Pseudomonas aeruginosa are immunogenic mediating a specific cell-mediated immune response. Protein engineering of the PHA inclusion forming enzyme by translational fusion of epitopes from vaccine candidates outer membrane proteins OprI, OprF, and AlgE mediated self-assembly of PHA inclusions coated by these selected antigens. Mice vaccinated with isolated PHA inclusions produced a Th1 type immune response characterized by antigen-specific production of IFN-γ and IgG2c isotype antibodies. This cell-mediated immune response was found to be associated with the production of functional antibodies reacting with cells of various P. aeruginosa strains as well as facilitating opsonophagocytic killing. This study showed that cellular inclusions of pathogenic bacteria are immunogenic and can be engineered to display selected antigens suitable to serve as particulate subunit vaccines against infectious diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Bacterial / immunology
  • Antibody Formation / immunology
  • Antigens, Bacterial / genetics
  • Antigens, Bacterial / immunology
  • Bacteria / genetics*
  • Bacteria / immunology*
  • Bacterial Infections / immunology*
  • Bacterial Infections / prevention & control
  • Bacterial Proteins / genetics
  • Bacterial Proteins / immunology
  • Bacterial Vaccines / administration & dosage
  • Bacterial Vaccines / immunology*
  • Bioengineering*
  • Cytokines / biosynthesis
  • Epitopes / immunology
  • Genetic Engineering
  • Humans
  • Immunity, Cellular*
  • Immunization
  • Mice
  • Mutation
  • Pseudomonas aeruginosa / immunology
  • Workflow

Substances

  • Antibodies, Bacterial
  • Antigens, Bacterial
  • Bacterial Proteins
  • Bacterial Vaccines
  • Cytokines
  • Epitopes